bild
GROSSBRITANNIEN CORONAVIRUS PHARMA IMPFSTOFF ASTRAZENECA
A general view of AstraZeneca offices and the corporate logo in Cambridge, England, Saturday, July 18, 2020. An Oxford University vaccine progress paper is to be published the the Lancet on Monday. Human trials of a potential coronavirus vaccine being developed by scientists are reported to have shown promising results. Pharmaceutical company AstraZeneca reached an agreement with Europe's Inclusive Vaccines Alliance (IVA) to supply up to 400 million doses of the University of Oxford's COVID-19 vaccine âÄ“ at no profit âÄ“ with deliveries starting by the end of 2020. (AP Photo/Alastair Grant)
Instruktionen
Lizenz
Rights Managed
Erstellungsdatum
20200718
Ort
CAMBRIDGE GROSSBRITANNIEN
Credit
KEYSTONE
Source
AP
Byline
ALASTAIR GRANT
Grösse
4572 x 3048 px
Dateityp
JPEG